A method of modulating the plasma half life of anti glypican 3 antibody, a pharmaceutical composition comprising as an active ingredient the anti glypican 3 antibody that has a plasma half life that has been modulated, a method of preparing the anti glypican 3 antibody and {HEAD ~ a pharmaceutical composition} comprising {TAIL ~ the anti glypican 3 antibody} as an active ingredient are provided 
comprising
A method of modulating the plasma half life of anti glypican 3 antibody , a pharmaceutical composition comprising as an active ingredient the anti glypican 3 antibody that has a plasma half life that has been modulated , a method of preparing the anti glypican 3 antibody and { HEAD ~ a pharmaceutical composition } comprising { TAIL ~ the anti glypican 3 antibody } as an active ingredient are provided
OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD HEAD REL TAIL TAIL TAIL TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH